Intratumor heterogeneity and transcriptional profiling in glioblastoma

Translational opportunities

Sara G.M. Piccirillo, Inmaculada Spiteri

Research output: Contribution to journalReview article

Abstract

The study of phenotypic and genetic intratumor heterogeneity in glioblastoma is attracting a lot of attention. Recent studies have demonstrated that transcriptional profiling analysis can help interpret the complexity of this disease. Previously proposed molecular classifiers have been recently challenged due to the unexpected degree of intratumor heterogeneity that has been described spatially and at single-cell level. Different computational methods have been employed to analyze this huge amount of data, but new experimental designs including multisampling from individual patients and single-cell experiments require new specific approaches. In light of these results, there is hope that integration of genetic, phenotypic and transcriptional data coupled with functional experiments might help define new therapeutic strategies and classify patients according to key pathways and molecular targets that can be further investigated to develop personalized and combinatorial treatment strategies.

Original languageEnglish (US)
Pages (from-to)369-381
Number of pages13
JournalFuture Neurology
Volume10
Issue number4
DOIs
StatePublished - Jul 1 2015

Fingerprint

Glioblastoma
Genetic Heterogeneity
Research Design
Therapeutics

Keywords

  • Cancer stem cells
  • Glioblastoma
  • Intratumor heterogeneity
  • Molecular classification
  • Transcriptional analysis

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Intratumor heterogeneity and transcriptional profiling in glioblastoma : Translational opportunities. / Piccirillo, Sara G.M.; Spiteri, Inmaculada.

In: Future Neurology, Vol. 10, No. 4, 01.07.2015, p. 369-381.

Research output: Contribution to journalReview article

@article{a8e5c4d22d1e4668ba9a45b9f0aaad44,
title = "Intratumor heterogeneity and transcriptional profiling in glioblastoma: Translational opportunities",
abstract = "The study of phenotypic and genetic intratumor heterogeneity in glioblastoma is attracting a lot of attention. Recent studies have demonstrated that transcriptional profiling analysis can help interpret the complexity of this disease. Previously proposed molecular classifiers have been recently challenged due to the unexpected degree of intratumor heterogeneity that has been described spatially and at single-cell level. Different computational methods have been employed to analyze this huge amount of data, but new experimental designs including multisampling from individual patients and single-cell experiments require new specific approaches. In light of these results, there is hope that integration of genetic, phenotypic and transcriptional data coupled with functional experiments might help define new therapeutic strategies and classify patients according to key pathways and molecular targets that can be further investigated to develop personalized and combinatorial treatment strategies.",
keywords = "Cancer stem cells, Glioblastoma, Intratumor heterogeneity, Molecular classification, Transcriptional analysis",
author = "Piccirillo, {Sara G.M.} and Inmaculada Spiteri",
year = "2015",
month = "7",
day = "1",
doi = "10.2217/FNL.15.16",
language = "English (US)",
volume = "10",
pages = "369--381",
journal = "Future Neurology",
issn = "1479-6708",
publisher = "Future Medicine Ltd.",
number = "4",

}

TY - JOUR

T1 - Intratumor heterogeneity and transcriptional profiling in glioblastoma

T2 - Translational opportunities

AU - Piccirillo, Sara G.M.

AU - Spiteri, Inmaculada

PY - 2015/7/1

Y1 - 2015/7/1

N2 - The study of phenotypic and genetic intratumor heterogeneity in glioblastoma is attracting a lot of attention. Recent studies have demonstrated that transcriptional profiling analysis can help interpret the complexity of this disease. Previously proposed molecular classifiers have been recently challenged due to the unexpected degree of intratumor heterogeneity that has been described spatially and at single-cell level. Different computational methods have been employed to analyze this huge amount of data, but new experimental designs including multisampling from individual patients and single-cell experiments require new specific approaches. In light of these results, there is hope that integration of genetic, phenotypic and transcriptional data coupled with functional experiments might help define new therapeutic strategies and classify patients according to key pathways and molecular targets that can be further investigated to develop personalized and combinatorial treatment strategies.

AB - The study of phenotypic and genetic intratumor heterogeneity in glioblastoma is attracting a lot of attention. Recent studies have demonstrated that transcriptional profiling analysis can help interpret the complexity of this disease. Previously proposed molecular classifiers have been recently challenged due to the unexpected degree of intratumor heterogeneity that has been described spatially and at single-cell level. Different computational methods have been employed to analyze this huge amount of data, but new experimental designs including multisampling from individual patients and single-cell experiments require new specific approaches. In light of these results, there is hope that integration of genetic, phenotypic and transcriptional data coupled with functional experiments might help define new therapeutic strategies and classify patients according to key pathways and molecular targets that can be further investigated to develop personalized and combinatorial treatment strategies.

KW - Cancer stem cells

KW - Glioblastoma

KW - Intratumor heterogeneity

KW - Molecular classification

KW - Transcriptional analysis

UR - http://www.scopus.com/inward/record.url?scp=84993967733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84993967733&partnerID=8YFLogxK

U2 - 10.2217/FNL.15.16

DO - 10.2217/FNL.15.16

M3 - Review article

VL - 10

SP - 369

EP - 381

JO - Future Neurology

JF - Future Neurology

SN - 1479-6708

IS - 4

ER -